Free Newsletter
India continues rise as a global drug power
Once notorious for cheap knockoffs, India is assuming a mainstream role in the global drug industry thanks to stronger patent protections and cost pressures on name-brand drug makers in the West. "Manufacturing, packaging and formulation are moving to India," says an industry consultant, who arranges tours of Indian factories for Western pharma execs thinking of outsourcing. Article
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: